Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC). - Wikidata - wikimedia - TriplyDB

Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).

Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).

http://www.wikidata.org/entity/Q36613950

about

The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family Regulated expression of ADAMTS-12 in human trophoblastic cells: a role for ADAMTS-12 in epithelial cell invasion?ADAM8: a new therapeutic target for asthma Structural and functional impact of cancer-related missense somatic mutations.A disintegrin and metalloproteinase-12 (ADAM12): function, roles in disease progression, and clinical implications ADAM-12 as a diagnostic marker for the proliferation, migration and invasion in patients with small cell lung cancer.Role of ADAM and ADAMTS metalloproteinases in airway diseases.The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migration ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors Dendritic cells from aged subjects contribute to chronic airway inflammation by activating bronchial epithelial cells under steady state.Expression of ADAMs and their inhibitors in sputum from patients with asthma.ADAMTS expression in colorectal cancer ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression.The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition.A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis.Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia.A-Disintegrin and Metalloproteinase (ADAM) 17 Enzymatically Degrades Interferon-gamma.Biomarker to distinguish hepatocellular carcinoma from cholangiocarcinoma by serum a disintegrin and metalloprotease 12.Association between ADAM12 Single-Nucleotide Polymorphisms and Knee Osteoarthritis: A Meta-Analysis.Upregulated expression levels of ADAM10 and EGFR and downregulated expression levels of E-cadherin in hepatocellular carcinomas.Differentially regulated ADAMTS1, 8, 9, and 18 in pancreas adenocarcinoma.ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy

P2860

Q21146633-8250B97E-B99A-4935-977C-E5A32201AC68 Q24299809-D37E6B7A-1467-4576-8415-B75AEBDBBC68 Q28590394-BCD388BF-D926-42C8-9011-5986D837E1AC Q30404960-190D0580-D267-4290-B033-C4B5682C094E Q30430629-3FD6DE70-1174-42EA-BD65-4F166DE65180 Q31148772-4CD19A11-04AA-42BB-AC5B-19598D3C175C Q33587176-DAE26228-F057-4B53-AABE-A16728524024 Q33593917-BB3477E9-FF6A-42DB-8476-281C10CD53FF Q33603746-9ACB714F-B44C-4D5C-9654-156F51A13E3D Q34381360-29E3966F-9D83-4931-842A-63915C2F8268 Q35113726-7A762C07-9E47-48C4-A512-41B94C1DF4F0 Q35191929-88FF97C4-328E-47C8-B617-0E73D4838C08 Q35560725-61B6E191-9FF2-44EF-9651-EB1A2C494099 Q35788620-0680FE2F-CF7E-4F4B-9D76-100B185A04AF Q35827939-3F85224F-85B6-4749-A918-7EA217FA399C Q36251710-A5BD153A-22E4-470F-9950-F7B777BAB695 Q36772590-F2D4295A-6102-48AA-A742-CCC964352F13 Q37215829-668BDB80-1491-4641-B2F6-EC734BF72281 Q40624156-FC187D9B-0DF4-476E-9D74-2C869C16A6F4 Q41451329-AEC43E3F-FB2B-4157-A724-2452AECEEB27 Q42077189-44BCF960-D2EA-476B-881E-B2B63CC33AB2 Q49305726-D1E934F1-4F62-4A17-AA5D-8A9D4C7FEBE6 Q59137239-F9AE9DC2-819D-4BAE-8AD3-FC142B991F34

P2860

Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).

http://www.wikidata.org/entity/Q36613950

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Expression of a disintegrin an ...... -cell lung carcinomas (NSCLC).

@ast

Expression of a disintegrin an ...... -cell lung carcinomas (NSCLC).

@en

type

label

Expression of a disintegrin an ...... -cell lung carcinomas (NSCLC).

@ast

Expression of a disintegrin an ...... -cell lung carcinomas (NSCLC).

@en

prefLabel

Expression of a disintegrin an ...... -cell lung carcinomas (NSCLC).

@ast

Expression of a disintegrin an ...... -cell lung carcinomas (NSCLC).

@en

P1433

Q36613950-12CF1EC6-6479-4B91-938E-4A89404DD817

P1476

Q36613950-F05B7944-0914-4D6B-BFCA-93C820D08563

P2093

Q36613950-013A920C-B1DD-46D2-A893-5E04EB961145

Q36613950-04D1D5B5-6A36-4FBC-8F1E-DE5DC75B3E1E

Q36613950-0E57340A-0834-4AD0-9DCA-F8E75D1E2731

Q36613950-2B641CB5-4AFF-4AC1-83C6-2597385D78B0

Q36613950-3B525610-5361-43B8-B29D-9E14A49F4E2A

Q36613950-830116BD-3F49-48F6-96BB-2159284F7F13

Q36613950-87D7AE16-77A7-415F-826F-2486EDF3B156

Q36613950-A8D505B9-46E5-4124-A78A-6AA182178893

Q36613950-AC6ADEA6-FCC3-4AA2-AC45-EB3B39D9BA1C

Q36613950-ED11125A-3A83-4E46-9D76-9FC3E828D79B

P2860

Q36613950-0F0781F2-013A-40A8-9461-EA28447320E5

Q36613950-0F507E7D-68A3-4261-99D8-7F376775529A

Q36613950-10DF77D9-2193-4F4A-92E8-339265206BFF

Q36613950-1134298C-A4D9-4302-B4AB-EA1F6CD13214

Q36613950-1B790E67-40D1-45F7-9E24-BA82D441EB67

Q36613950-25E01B98-6C6F-4068-9B02-599CF5521E4A

Q36613950-26B6B267-0EA1-435D-8406-85B5F064B61C

Q36613950-26BDC32B-3CF7-4515-8913-387FEFA2ED09

Q36613950-26D03912-D848-49DB-8AFC-A54F6991E290

Q36613950-288DC4FE-E8C4-459D-96A9-74448F55B00C

P2888

Q36613950-E67F9D97-6754-4C19-A256-74A1DC67969F

P304

Q36613950-B41ED141-77BE-4E2A-A9A5-E469AE060267

P31

Q36613950-83E91606-4E0D-42B0-93EF-78B9E2376EC9

P356

Q36613950-AA4E3E24-C307-4B52-9512-0F9CC55CFF03

P407

Q36613950-E2CF381F-3768-4C11-8AE5-5DFFB8C3C84C

P433

Q36613950-080CB6C0-E31D-4656-9D2F-728F5E8C969B

P478

Q36613950-2DEE8182-722E-41E2-93A4-87A4BB9A5F1F

P577

Q36613950-D6FAC9FA-CF8D-47F9-9130-B82933426F4F

P5875

Q36613950-D61A8906-E26E-4785-991E-1B31C3E6BADF

P6179

Q36613950-873FE282-4902-402A-90CD-2F26EB02A4F2

P698

Q36613950-673E69FB-A7F1-426A-A54A-4A7B26EFE6F8

P932

Q36613950-91AE5C48-0259-423C-A4E1-A77F5BEFB877

P356

P1433

British Journal of Cancer

P1476

Expression of a disintegrin an ...... -cell lung carcinomas (NSCLC).

@en

P2093

A Noel

http://www.w3.org/2001/XMLSchema#string

C Munaut

http://www.w3.org/2001/XMLSchema#string

D Cataldo

http://www.w3.org/2001/XMLSchema#string

F Quesada Calvo

http://www.w3.org/2001/XMLSchema#string

G Paulissen

http://www.w3.org/2001/XMLSchema#string

J-M Foidart

http://www.w3.org/2001/XMLSchema#string

M Gueders

http://www.w3.org/2001/XMLSchema#string

M Polette

http://www.w3.org/2001/XMLSchema#string

N Rocks

http://www.w3.org/2001/XMLSchema#string

P Birembaut

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene

A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo

METH-2 silencing and promoter hypermethylation in NSCLC

The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

Human and mouse proteases: a comparative genomic approach

ADAMTS: a novel family of extracellular matrix proteases

ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165

Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases

ADAM8 as a novel serological and histochemical marker for lung cancer

P2888

P304

724-730

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6602990

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46388056

http://www.w3.org/2001/XMLSchema#string

P6179

1036763603

http://www.w3.org/2001/XMLSchema#string

P698

16495931

http://www.w3.org/2001/XMLSchema#string

P932

2361209

http://www.w3.org/2001/XMLSchema#string